Patient-Reported Outcomes from Patients with Waldenstrom Macroglobulinemia Treated with Ibrutinib-Rituximab: Results from iNNOVATE Study

被引：0

作者：

Matous, Jeffrey V. ^{[1
]}

Tedeschi, Alessandra ^{[2
]}

Dimopoulos, Meletios A. ^{[3
]}

Trotman, Judith ^{[4
]}

Garcia-Sanz, Ramon ^{[5
]}

Macdonald, David ^{[6
]}

Mahe, Beatrice ^{[7
]}

Herbaux, Charles ^{[8
]}

Heffner, Leonard ^{[9
]}

Tam, Constantine S. ^{[10
,11
,12
]}

Varettoni, Marzia ^{[13
]}

Palomba, M. Lia ^{[14
]}

Shustik, Chaim ^{[15
]}

Kastritis, Efstathios ^{[3
]}

Treon, Steven P. ^{[16
]}

Li, Jianling ^{[17
]}

Poulsen, Erik G. ^{[17
]}

Hauns, Bernhard ^{[17
]}

Buske, Christian ^{[18
]}

Leblond, Veronique ^{[19
]}

机构：

[1] Colorado Blood Canc Inst, Denver, CO USA

[2] ASST Grande Osped Metropolitano Niguarda, Milan, Italy

[3] Univ Athens, Sch Med, Athens, Greece

[4] Univ Sydney, Concord Hosp, Sydney, NSW, Australia

[5] Hosp Univ Salamanca, Salamanca, Spain

[6] Univ Ottawa, Ottawa Hosp, Ottawa, ON, Canada

[7] CHU Nantes, Nantes, France

[8] Ctr Hosp Reg Univ Lille, Inst Hematol Transfus, Lille, France

[9] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[10] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[11] St Vincents Hosp, Melbourne, Vic, Australia

[12] Univ Melbourne, Melbourne, Vic, Australia

[13] Fdn IRCCS Policlin San Matteo, Pavia, Italy

[14] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[15] McGill Univ, Hlth Ctr, Royal Victoria Hosp, Montreal, PQ, Canada

[16] Dana Farber Canc Inst, Boston, MA 02115 USA

[17] Pharmacyclics LLC, Sunnyvale, CA USA

[18] Univ Hosp Ulm, Ulm, Germany

[19] Sorbonne Univ Paris, Hop Pitie Salpetriere, AP HP, Paris, France

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2019年 / 94卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P-019

引用

下载

页码：S14 / S15

页数：2

共 50 条

[1] Patient-reported outcomes (PROs) with ibrutinib-rituximab in Waldenstrom macroglobulinemia (WM): Results from iNNOVATE.
Tedeschi, Alessandra
Dimopoulos, Meletios A.
Trotman, Judith
Garcia-Sanz, Ramon
MacDonald, David
Mahe, Beatrice
Herbaux, Charles
Heffner, Leonard T.
Tam, Constantine Si Lun
Varettoni, Marzia
Palomba, Maria Lia
Matous, Jeffrey
Shustik, Chaim
Kastritis, Efstathios
Treon, Steven P.
Li, Jianling
Poulsen, Erik
Hauns, Bernhard
Buske, Christian
Leblond, Veronique
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[2] PATIENT-REPORTED OUTCOMES (PROS) WITH IBRUTINIB: SUBSTUDY OF INNOVATETM FOR WALDENSTROM MACROGLOBULINEMIA (WM)
Trotman, J.
Dimopoulos, M. A.
Tedeschi, A.
Matous, J. V.
Heffner, L. T.
Shustik, C.
Garcia-Sanz, R.
Castillo, J. J.
Leblond, V.
Kastritis, E.
Li, J.
Graef, T.
Bilotti, E.
Buske, C.
HAEMATOLOGICA, 2017, 102 : 510 - 510
[3] Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenstrom's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study
Buske, Christian
Tedeschi, Alessandra
Trotman, Judith
Garcia-Sanz, Ramon
MacDonald, David
Leblond, Veronique
Mahe, Beatrice
Herbaux, Charles
Matous, Jeffrey V.
Tam, Constantine S.
Heffner, Leonard T.
Varettoni, Marzia
Palomba, M. Lia
Shustik, Chaim
Kastritis, Efstathios
Treon, Steven P.
Ping, Jerry
Hauns, Bernhard
Arango-Hisijara, Israel
Dimopoulos, Meletios A.
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (01) : 52 - +
[4] Impact of ibrutinib dose intensity on patient outcomes in previously treated Waldenstrom macroglobulinemia
Castillo, Jorge J.
Gustine, Joshua N.
Meid, Kirsten
Dubeau, Toni E.
Xu, Lian
Yang, Guang
Hunter, Zachary R.
Advani, Ranjana
Palomba, Lia
Treon, Steven P.
HAEMATOLOGICA, 2018, 103 (10) : E466 - E468
[5] Impact of Ibrutinib Dose Intensity on Patient Outcomes in Previously Treated Waldenstrom Macroglobulinemia
Gustine, Joshua
Meid, Kirsten
Dubeau, Toni
Severns, Patricia
Treon, Steven P.
Castillo, Jorge J.
BLOOD, 2017, 130
[6] Ibrutinib Treatment in Waldenstrom's Macroglobulinemia: Follow-up Efficacy and Safety from the iNNOVATE™ Study
Buske, Christian
Tedeschi, Alessandra
Trotman, Judith
Garcia-Sanz, Ramon
MacDonald, David
Leblond, Veronique
Mahe, Beatrice
Herbaux, Charles
Tam, Constantine S.
Palomba, M. Lia
Matous, Jeffrey V.
Shustik, Chaim
Kastritis, Eftathios
Treon, Steven P.
Lih, Chih-Jian
Li, Jianling
Salman, Zeena
Graef, Thorsten
Dimopoulos, Meletios A.
BLOOD, 2018, 132
[7] Ibrutinib Therapy in Rituximab-Refractory Patients with Waldenstrom's Macroglobulinemia: Initial Results from an International, Multicenter, Open-Label Phase 3 Substudy (iNNOVATE™)
Dimopoulos, Meletios A.
Trotman, Judith
Tedeschi, Alessandra
Matous, Jeffrey V.
Macdonald, David
Tam, Constantine
Tournilhac, Oliver
Ma, Shuo
Oriol, Albert
Heffner, Leonard T.
Shustik, Chaim
Garcia-Sanz, Ramon
Cornelli, Robert F.
Fernandez de Larrea, Carlos
Castillo, Jorge J.
Granell, Miquel
Kyrtsonis, Marie-Christine
Leblond, Veronique
Svmeonidis, Argiris
Singh, Priyanka
Li, Jianling
Graef, Thorsten
Bilotti, Elizabeth
Treon, Steven
Buske, Christian
BLOOD, 2015, 126 (23)
[8] NURSING EXPERIENCE WITH PATIENTS RECEIVING IBRUTINIB PLUS RITUXIMAB VERSUS PLACEBO PLUS RITUXIMAB FOR WALDENSTROM'S MACROGLOBULINEMIA: FIVE YEARS OF FOLLOW-UP FROM THE PHASE 3 INNOVATE™ STUDY
Adewuya, Tolu
Mimken, Kate
Hauns, Bernhard
Arango-Hisijara, Israel
Matous, Jeffrey
Heffner, Leonard
ONCOLOGY NURSING FORUM, 2021, 48 (02)
[9] Ibrutinib treatment in Waldenstrom's macroglobulinemia (WM): follow-up results of the phase 3 iNNOVATE™ study
Buske, C.
Tedeschi, A.
Trotman, J.
Garcia-Sanz, R.
Macdonald, D.
Leblond, V.
Mahe, B.
Herbaux, C.
Tam, C. S.
Palomba, M. L.
Matous, J. V.
Shustik, C.
Kastritis, E.
Treon, S. P.
Lih, C. -J.
Li, J.
Salman, Z.
Graef, T.
Dimopoulos, M. A.
ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 158 - 158
[10] Plain Language Summary of the iNNOVATE study: ibrutinib plus rituximab is well-tolerated and effective in people with Waldenstrom's macroglobulinemia
Buske, Christian
Tedeschi, Alessandra
Trotman, Judith
Garcia-Sanz, Ramon
MacDonald, David
Leblond, Veronique
Mahe, Beatrice
Herbaux, Charles
Matous, Jeffrey, V
Tam, Constantine S.
Heffner, Leonard T.
Varettoni, Marzia
Palomba, M. Lia
Shustik, Chaim
Kastritis, Efstathios
Treon, Steven P.
Ping, Jerry
Hauns, Bernhard
Arango-Hisijara, Israel
Dimopoulos, Meletios A.
FUTURE ONCOLOGY, 2023, 19 (05) : 345 - 353

← 1 2 3 4 5 →